Tumor Derived Extracellular Vesicles Modulate Gene Expression in T cells

Extracellular vesicles (EVs) are excreted from all cells in the human body and are heterogeneous lipid bilayer particles containing proteins, RNA, DNA, and other cargo. T cells are primary players of the adaptive immune system and have a significant role in anti-cancer immunotherapies. Tumor derived EVs have diverse effects on host cells including modulating the immune response. In this study, we investigate the role acute myeloid leu-kemia (AML) derived EVs have on modulation of gene expression levels in three different T cell populations (CD8+, CD4+, and CD4 + CD39 + T cells). AML derived EVs modulate gene expression levels in all three cell populations with transcripts associated with major immunoregulatory pathways being significantly altered. Genes whose expression were significantly upregulated or downregulated were analyzed for gene ontogeny category expression and for the impact of the changes on specific immunoregulatory pathways. CD8 + T cells were modulated to a larger extent than other T cell populations and gene expression levels associated with proliferation and differentiation were influenced by AML-derived EVs.

Automated summary

Extracellular vesicles (EVs), which are lipid bilayer particles containing various substances, are excreted from all cells in the human body. In this study, researchers investigated the effects of acute myeloid leukemia (AML)-derived EVs on gene expression levels in three different T cell populations, finding that these EVs modulate gene expression and significantly impact immunoregulatory pathways.